Molecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A Protease

被引:42
|
作者
Romano, Keith P. [1 ]
Laine, Jennifer M. [1 ]
Deveau, Laura M. [1 ]
Cao, Hong [1 ]
Massi, Francesca [1 ]
Schiffer, Celia A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; INHIBITOR; REPLICATION; VARIANTS; CLEAVAGE;
D O I
10.1128/JVI.00377-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C NS3/4A protease is a prime therapeutic target that is responsible for cleaving the viral polyprotein at junctions 3-4A, 4A4B, 4B5A, and 5A5B and two host cell adaptor proteins of the innate immune response, TRIF and MAVS. In this study, NS3/4A crystal structures of both host cell cleavage sites were determined and compared to the crystal structures of viral substrates. Two distinct protease conformations were observed and correlated with substrate specificity: (i) 3-4A, 4A4B, 5A5B, and MAVS, which are processed more efficiently by the protease, form extensive electrostatic networks when in complex with the protease, and (ii) TRIF and 4B5A, which contain polyproline motifs in their full-length sequences, do not form electrostatic networks in their crystal complexes. These findings provide mechanistic insights into NS3/4A substrate recognition, which may assist in a more rational approach to inhibitor design in the face of the rapid acquisition of resistance.
引用
收藏
页码:6106 / 6116
页数:11
相关论文
共 50 条
  • [31] Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design
    Oezen, Ayseguel
    Sherman, Woody
    Schiffer, Celia A.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2013, 9 (12) : 5693 - 5705
  • [32] Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons
    Asante-Appiah, Ernest
    Curry, Stephanie
    McMonagle, Patricia
    Ingravallo, Paul
    Chase, Robert
    Nickle, David
    Qiu, Ping
    Howe, Anita
    Lahser, Frederick C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [33] Establishment of a novel triple-transgenic mouse: conditionally and liver-specifically expressing hepatitis C virus NS3/4A protease
    Lan, H. Y.
    Zhao, Y.
    Yang, J.
    Sun, M. N.
    Lei, Y. F.
    Yao, M.
    Huang, X. J.
    Zhang, J. M.
    Xu, Z. K.
    Lu, X.
    Yin, W.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (11) : 7349 - 7359
  • [34] MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
    Summa, Vincenzo
    Ludmerer, Steven W.
    McCauley, John A.
    Fandozzi, Christine
    Burlein, Christine
    Claudio, Giuliano
    Coleman, Paul J.
    DiMuzio, Jillian M.
    Ferrara, Marco
    Di Filippo, Marcello
    Gates, Adam T.
    Graham, Donald J.
    Harper, Steven
    Hazuda, Darla J.
    McHale, Carolyn
    Monteagudo, Edith
    Pucci, Vincenzo
    Rowley, Michael
    Rudd, Michael T.
    Soriano, Aileen
    Stahlhut, Mark W.
    Vacca, Joseph P.
    Olsen, David B.
    Liverton, Nigel J.
    Carroll, Steven S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4161 - 4167
  • [35] Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections
    Venkatraman, Srikanth
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 289 - 294
  • [36] Fuel Specificity of the Hepatitis C Virus NS3 Helicase
    Belon, Craig A.
    Frick, David N.
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 388 (04) : 851 - 864
  • [37] Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
    Zeminian, Luciana Bonome
    Padovani, Juliana Lara
    Corvino, Silvia Maria
    Silva, Giovanni Faria
    de Moura Campos Pardini, Maria Ines
    Tommasini Grotto, Rejane Maria
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2013, 108 (01): : 13 - 17
  • [38] NS3 Protease from Hepatitis C Virus: Biophysical Studies on an Intrinsically Disordered Protein Domain
    Vega, Sonia
    Neira, Jose L.
    Marcuello, Carlos
    Lostao, Anabel
    Abian, Olga
    Velazquez-Campoy, Adrian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07): : 13282 - 13306
  • [39] Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy
    Ndjomou, Jean
    Corby, M. Josie
    Sweeney, Noreena L.
    Hanson, Alicia M.
    Aydin, Cihan
    Ali, Akbar
    Schiffer, Celia A.
    Li, Kelin
    Frankowski, Kevin J.
    Schoenen, Frank J.
    Frick, David N.
    ACS CHEMICAL BIOLOGY, 2015, 10 (08) : 1887 - 1896
  • [40] Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins
    Massariol, Marie-Josee
    Zhao, Songping
    Marquis, Martin
    Thibeault, Diane
    White, Peter W.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 692 - 697